Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

NCT04730024 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

OTHER: Not applicable(observational study)

Sponsor

Kang Stem Biotech Co., Ltd.